Nuveen Asset Management’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $787K | Hold |
95,706
| – | – | ﹤0.01% | 2808 |
|
2024
Q3 | $853K | Sell |
95,706
-32,240
| -25% | -$287K | ﹤0.01% | 2823 |
|
2024
Q2 | $967K | Buy |
127,946
+57,697
| +82% | +$436K | ﹤0.01% | 2741 |
|
2024
Q1 | $551K | Hold |
70,249
| – | – | ﹤0.01% | 2945 |
|
2023
Q4 | $622K | Buy |
70,249
+10,134
| +17% | +$89.8K | ﹤0.01% | 2934 |
|
2023
Q3 | $539K | Hold |
60,115
| – | – | ﹤0.01% | 2822 |
|
2023
Q2 | $742K | Buy |
60,115
+5,824
| +11% | +$71.9K | ﹤0.01% | 2777 |
|
2023
Q1 | $504K | Buy |
54,291
+5,252
| +11% | +$48.8K | ﹤0.01% | 2802 |
|
2022
Q4 | $515K | Sell |
49,039
-12,685
| -21% | -$133K | ﹤0.01% | 2878 |
|
2022
Q3 | $1.12M | Buy |
61,724
+497
| +0.8% | +$9.01K | ﹤0.01% | 2698 |
|
2022
Q2 | $868K | Buy |
+61,227
| New | +$868K | ﹤0.01% | 2851 |
|